Resultados de la búsqueda 101-110 of 10716 for Vitiligo

  1. Carcinoma hepatocelular

    Hepatocellular carcinoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1514. Accessed July 25, 2025.

  2. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The purpose of this study is to develop a registry to collect long-term data on patients with pediatric cutaneous mastocytosis, and develop ...

  3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The purpose of this study is to build a National Registry of individuals with one of the group of primary immune deficiency diseases. A " ...

  4. Carcinoma hepatocelular

    Los médicos y científicos de Mayo Clinic estudian maneras nuevas de mejorar el diagnóstico y el tratamiento del carcinoma hepatocelular.

  5. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma that has come ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Giving the personalized neoantigen peptide-based vaccine with pembrolizumab may be safe and effective in treating patients with advanced solid tumors.

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for ...

  9. Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet. Dec. 14, 2021 . VID-20522540.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive ...